ABT vs ARLO · P/E 25, rev $44.33B vs rev $306.3M
Abbott Laboratories (ABT) versus Arlo Technologies (ARLO) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Arlo Technologies (ARLO) is a building products & equipment company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ARLO revenue for 2026-06-28 was $306.3M. Net income was $17.9M. ARLO currently screens at market cap $1.78B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ARLO currently screens at market cap $1.78B.
Not investment advice. Open the ABT and ARLO stock pages for the full models.
Not investment advice.